Peritoneal carcinomatosis: Patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

World Journal of Surgical Oncology

Volumn 7, Issue , 2009, Pages

  Glockzin, Gabriel ^a   Schlitt, Hans J ^a   Piso, Pompiliu ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; CYTOSTATIC AGENT; DOXORUBICIN; MITOMYCIN; MITOXANTRONE; OXALIPLATIN; ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; CLINICAL TRIAL; CYTOREDUCTIVE SURGERY; DRUG PENETRATION; HUMAN; HYPERTHERMIC THERAPY; MORBIDITY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; PERIOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; QUALITY OF LIFE; REVIEW; SURGICAL MORTALITY; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT RESPONSE; METASTASIS; MULTIMODALITY CANCER THERAPY; PERITONEUM TUMOR;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; PATIENT SELECTION; PERITONEAL NEOPLASMS; QUALITY OF LIFE;

EID: 60749124179     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-7-5     Document Type: Review

References (52)

1. Sadeghi B Arvieux C Glehen O Beaujard AC Rivoire M Baulieux J Fontaumard E Brachet A Caillot JL Faure JL Porcheron J Peix JL François Y Vignal J Gilly FN: Peritoneal carcinomatosis from non-gynecologic malignancies: Results of the EVOCAPE 1 multicentric prospective study. Cancer 2000, 88:358-363. 10.1002/ (SICI)1097-0142(20000115)88:2<358::AID-CNCR16>3.0.CO;2-O 10640968
2. Hardy JR Wiltshaw E Blake PR Harper P Slevin M Perren TJ Tan S: Cisplatin and carboplatin in combination for the treatment of stage IV ovarian carcinoma. Ann Oncol 1991, 2:131-136. 2054315
3. Curtin JP Malik R Venkatraman ES Barakat RR Hoskins WJ: Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol 1997, 64:9-12. 10.1006/gyno.1996.4550 8995540
4. Akahira JI Yoshikawa H Shimizu Y Tsunematsu R Hirakawa T Kuramoto H Shiromizu K Kuzuya K Kamura T Kikuchi Y Kodama S Yamamoto K Sato S: Prognostic factors of stage IV epithelial ovarian cancer: A multicenter retrospective study. Gynecol Oncol 2001, 81:398-403. 10.1006/ gyno.2001.6172 11371128
5. Yan TD Brun EA Cerruto CA Haveric N Chang D Sugarbaker PH: Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma. Ann Surg Oncol 2007, 14:41-49. 10.1245/ s10434-006-9169-7 17039392
6. Eltabbakh GH Piver MS Hempling RE Recio FO Intengen ME: Clinical picture, response to therapy, and survival of women with diffuse malignant peritoneal mesothelioma. J Surg Oncol 1999, 70:6-12. 10.1002/ (SICI)1096-9098(199901)70:1<6::AID-JSO2>3.0.CO;2-X 9989414
7. Neumann V Muller KM Fischer M: [Peritoneal mesothelioma - incidence and etiology]. Pathologe 1999, 20:169-176. 10.1007/s002920050340 10412176
8. Simon GR Verschraegen CF Jänne PA Langer CJ Dowlati A Gadgeel SM Kelly K Kalemkerian GP Traynor AM Peng G Gill J Obasaju CK Kindler HL: Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma: Final report of a phase II trial. J Clin Oncol 2008, 26:3567-3572. 10.1200/JCO.2007.15.2868 18640937
9. Glockzin G Ghali N Lang SA Agha A Schlitt HJ Piso P: [Peritoneal carcinomatosis. Surgical treatment, including hyperthermic intraperitoneal chemotherapy]. Chirurg 2007, 78:1102-1106. 10.1007/ s00104-007-1419-0
10. Bristow RE Tomacruz RS Armstrong DK Trimble EL Montz FJ: Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis. J Clin Oncol 2002, 20:1248-1259. 10.1200/JCO.20.5.1248 11870167
11. Sugarbaker PH Cunliffe WJ Belliveau J de Bruijn EA Graves T Mullins RE Schlag P: Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 1989, 16:83-97. 2669141
12. Sugarbaker PH: New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? Lancet Oncol 2006, 7:69-76. 10.1016/ S1470-2045(05)70539-8 16389186
13. Jacquet P Sugarbaker PH: Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 1996, 82:359-374. 8849962
14. Glehen O Gilly FN: Quantitative prognostic indicators of peritoneal surface malignancy: Carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 2003, 12:649-671. 10.1016/ S1055-3207(03)00037-1 14567023
15. Sugarbaker PH: Laboratory and clinical basis for hyperthermia as a component of intracavitary chemotherapy. Int J Hyperthermia 2007, 23:431-442. 10.1080/02656730701455318 17701534
16. Glehen O Cotte E Kusamura S Deraco M Baratti D Passot G Beaujard AC Noel GF: Hyperthermic intraperitoneal chemNtherapy: nomenclature and modalities of perfusion. J Surg Oncol 2008, 98:242-246. 10.1002/ jso.21061 18726885
17. Yan TD Morris DL Shigeki K Dario B Marcello D: Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: Expert consensus statement. J Surg Oncol 2008, 98:224-227. 10.1002/ jso.21069 18726881
18. Deraco M Bartlett D Kusamura S Baratti D: Consensus statement on peritoneal mesothelioma. J Surg Oncol 2008, 98:268-272. 10.1002/ jso.21055 18726890
19. Sugarbaker PH Welch LS Mohamed F Glehen O: A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am 2003, 12:605-621. 10.1016/S1055-3207(03)00045-0 14567020
20. Esquivel J Elias D Baratti D Kusamura S Deraco M: Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 2008, 98:263-267. 10.1002/jso.21053 18726889
21. Bozzetti F Yu W Baratti D Kusamura S Deraco M: Locoregional treatment of peritoneal carcinomatosis from gastric cancer. J Surg Oncol 2008, 98:273-276. 10.1002/jso.21052 18726891
22. Moran B Baratti D Yan TD Kusamura S Deraco M: Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol 2008, 98:277-282. 10.1002/jso.21054 18726894
23. Esquivel J Sticca R Sugarbaker P Levine E Yan TD Alexander R Baratti D Bartlett D Barone R Barrios P Bieligk S Bretcha-Boix P Chang CK Chu F Chu Q Daniel S de Bree E Deraco M Dominguez-Parra L Elias D Flynn R Foster J Garofalo A Gilly FN Glehen O Gomez-Portilla A Gonzalez-Bayon L Gonzalez-Moreno S Goodman M Gushchin V Hanna N Hartmann J Harrison L Hoefer R Kane J Kecmanovic D Kelley S Kuhn J Lamont J Lange J Li B Loggie B Mahteme H Mann G Martin R Misih RA Moran B Morris D Onate-Ocana L Petrelli N Philippe G Pingpank J Pitroff A Piso P Quinones M Riley L Rutstein L Saha S Alrawi S Sardi A Schneebaum S Shen P Shibata D Spellman J Stojadinovic A Stewart J Torres-Melero J Tuttle T Verwaal V Villar J Wilkinson N Younan R Zeh H Zoetmulder F Sebbag G: Society of Surgical Oncology Annual Meeting Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: A consensus statement. Society of Surgical Oncology. Ann Surg Oncol 2007, 14:128-133. 17072675
24. Helm CW Bristow RE Kusamura S Baratti D Deraco M: Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer. J Surg Oncol 2008, 98:283-290. 10.1002/ jso.21083 18726895
25. Verwaal VJ van Ruth S de Bree E van Sloothen GW van Tinteren H Boot H Zoetmulder FA: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003, 21:3737-3743. 10.1200/JCO.2003.04.187 14551293
26. Di Giorgio A Naticchioni E Biacchi D Sibio S Accarpio F Rocco M Tarquini S Di Seri M Ciardi A Montruccoli D Sammartino P: Cytoreductive surgery (peritonectomy procedures) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of diffuse peritoneal carcinomatosis from ovarian cancer. Cancer 2008, 113:315-325. 10.1002/ cncr.23553 18473354
27. Yan TD Edwards G Alderman R Marquardt CE Sugarbaker PH: Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma - a prospective study of 70 consecutive cases. Ann Surg Oncol 2007, 14:515-525. 10.1245/s10434-006-9187-5 17031722
28. Hirose K Katayama K Iida A Yamaguchi A Nakagawara G Umeda S Kusaka Y: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 1999, 57:106-114. 10.1159/000012016 10461056
29. Glehen O Schreiber V Cotte E Sayag-Beaujard AC Osinsky D Freyer G Francois Y Vignal J Gilly FN: Cytoreductive surgery and intraperitoneal chemohyperthermia for peritoneal carcinomatosis arising from gastric cancer. Arch Surg 2004, 139:20-26. 10.1001/archsurg.139.1.20 14718269
30. Yonemura Y Kawamura T Bandou E Takahashi S Sawa T Matsuki N: Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 2005, 92:370-375. 10.1002/bjs.4695 15739249
31. Cheong JH Shen JY Song CS Hyung WJ Shen JG Choi SH Noh SH: Early postoperative intraperitoneal chemotherapy following cytoreductive surgery in patients with very advanced gastric cancer. Ann Surg Oncol 2007, 14:61-68. 10.1245/s10434-006-9205-7 17058123
32. Culliford AT 4th Brooks AD Sharma S Saltz LB Schwartz GK O'Reilly EM Ilson DH Kemeny NE Kelsen DP Guillem JG Wong WD Cohen AM Paty PB: Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001, 8:787-795. 10.1007/s10434-001-0787-9 11776492
33. Glehen O Kwiatkowski F Sugarbaker PH Elias D Levine EA De Simone M Barone R Yonemura Y Cavaliere F Quenet F Gutman M Tentes AA Lorimier G Bernard JL Bereder JM Porcheron J Gomez-Portilla A Shen P Deraco M Rat P: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004, 22:3284-3292. 10.1200/JCO.2004.10.012 15310771
34. Shen P Hawksworth J Lovato J Loggie BW Geisinger KR Fleming RA Levine EA: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004, 11:178-186. 10.1245/ ASO.2004.05.009 14761921
35. Feldman AL Libutti SK Pingpank JF Bartlett DL Beresnev TH Mavroukakis SM Steinberg SM Liewehr DJ Kleiner DE Alexander HR: Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy. J Clin Oncol 2003, 21:4560-4567. 10.1200/JCO.2003.04.150 14673042
36. Deraco M Nonaka D Baratti D Casali P Rosai J Younan R Salvatore A Cabras Ad AD Kusamura S: Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion. Ann Surg Oncol 2006, 13:229-237. 10.1245/ASO.2006.03.045 16444562
37. Piso P Dahlke MH Loss M Schlitt HJ: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in peritoneal carcinomatosis from ovarian cancer. World J Surg Oncol 2004, 2:21. 446210 15222884 10.1186/1477-7819-2-21
38. Cotte E Glehen O Mohamed F Lamy F Falandry C Golfier F Gilly FN: Cytoreductive surgery and intraperitoneal chemo-hyperthermia for chemo-resistant and recurrent advanced epithelial ovarian cancer: prospective study of 81 patients World. J Surg 2007, 31:1813-1820. 10.1007/s00268-007-9146-8 17629740
39. Hansson J Graf W Pahlman L Nygren P Mahteme H: Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 2008. 18514475
40. Younan R Kusamura S Baratti D Cloutier AS Deraco M: Morbidity, toxicity, and mortality classification systems in the local regional treatment of peritoneal surface malignancy. J Surg Oncol 2008, 98:253-257. 10.1002/ jso.21057 18726887
41. Verwaal VJ Bruin S Boot H van Slooten G van Tinteren: H 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008, 15:2426-2432. 10.1245/s10434-008-9966-2 18521686
42. Elias D Delperro JR Sideris L Benhamou E Pocard M Baton O Giovannini M Lasser P: Treatment of peritoneal carcinomatosis from colorectal cancer: impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004, 11:518-521. 10.1245/ ASO.2004.09.008 15123461
43. Mahteme H Hansson J Berglund A Pahlman L Glimelius B Nygren P Graf W: Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study. Br J Cancer 2004, 90:403-407. 10.1038/ sj.bjc.6601586 14735184
44. Fujimoto S Takahashi M Mutou T Kobayashi K Toyosawa T Isawa E Sumida M Ohkubo H: Improved mortality rate of gastric carcinoma patients with peritoneal carcinomatosis treated with intraperitoneal hyperthermic chemoperfusion combined with surgery. Cancer 1997, 79:884-891. 10.1002/ (SICI)1097-0142(19970301)79:5<884::AID-CNCR3>3.0.CO;2-C 9041149
45. Hall JJ Loggie BW Shen P Beamer S Douglas Case L McQuellon R Geisinger KR Levine EA: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for advanced gastric cancer. J Gastrointest Surg 2004, 8:454-463. 10.1016/j.gassur.2003.12.014 15120371
46. Yonemura Y Bandou E Kawamura T Endou Y Sasaki T: Quantitative prognostic indicators of peritoneal dissemination of gastric cancer. Eur J Surg Oncol 2006, 32:602-606. 10.1016/j.ejso.2006.03.003 16617004
47. Yan TD Welch L Black D Sugarbaker PH: A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol 2007, 18:827-834. 10.1093/annonc/mdl428 17130182
48. Schmidt U Dahlke MH Klempnauer J Schlitt HJ Piso P: Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 2005, 31:53-58. 10.1016/j.ejso.2004.09.011 15642426
49. McQuellon RP Loggie BW Fleming RA Russell GB Lehman AB Rambo TD: Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis. Eur J Surg Oncol 2001, 27:65-73. 10.1053/ ejso.2000.1033 11237495
50. McQuellon RP Loggie BW Lehman AB Russell GB Fleming RA Shen P Levine EA: Long-term survivorship and quality of life after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2003, 10:155-162. 10.1245/ASO.2003.03.067 12620911
51. Tuttle TM Zhang Y Greeno E Knutsen A: Toxicity and quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol 2006, 13:1627-1632. 10.1245/s10434-006-9186-6 17013686
52. McQuellon RP Danhauer SC Russell GB Shen P Fenstermaker J Stewart JH Levine EA: Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann Surg Oncol 2007, 14:1105-1113. 10.1245/ s10434-006-9304-5 17206478